Imre (Imi) Kovesdi

Current

• Chief Executive Officer at VectorLogics, Inc.
• President at KILA Consultants, LLC

Past

• Vice President & Chief Scientific Officer at GenVec, Inc.
• Group Leader at AMERICAN CYANAMID

Education

• Rockefeller University
• Simon Fraser University
• The University of British Columbia

Connections

22 connections

Industry

Biotechnology

Imre (Imi) Kovesdi’s Summary

Senior Science Executive with over 20 years in the research, discovery and development of therapeutic drugs in both large pharmaceutical and biotechnology environments. A creative strategist able to see the broader scientific and business needs and break them down to specific programs and projects, and direct them to completion. Versatile facilitator, skilled at developing pre-clinical, clinical and licensing partnerships, able to identify foundation solutions to major health issues. Publisher of over 125 technical papers and holder of over 70 US and Foreign patents with another 10 in different stages of prosecution.

Imre (Imi) Kovesdi’s Specialties:

Specializing in biotechnology, drug development and gene delivery strategies.

Additional Information

Imre (Imi) Kovesdi’s Groups:

American Association for the Advancement of Science (AAAS)
American Society for Microbiology (ASM)
American Society for Virology (ASV)
The Institute of Electrical and Electronics Engineers (IEEE)
An International Association for Pharmaceutical Science and Technology (PDA)
Drug Information Association (DIA)
The American Society of Gene Therapy (ASGT)
European Society of Gene Therapy (ESGT)

•    Tech Council of Maryland
•    Biotech & Pharma Professionals Network
•    Medical Device Professionals Network

Imre (Imi) Kovesdi’s Contact Settings

Interested In:

• career opportunities
• consulting offers
• new ventures
• expertise requests
• business deals
• reference requests
• getting back in touch